Authors:
JOVER B
DEMEILLIERS B
HERIZI A
NISATO D
CAZAUBON C
MIMRAN A
Citation: B. Jover et al., IRBESARTAN BUT NOT ENALAPRIL REVERSES ALTERATION OF RENAL-FUNCTION ASSOCIATED WITH L-NAME HYPERTENSION, Journal of hypertension, 16, 1998, pp. 1534-1534
Authors:
SERRE M
MATTEI PP
RICHAUD JP
CAZAUBON C
GAUTIER P
NISATO D
Citation: M. Serre et al., ANTIARRHYTHMIC EFFECTS OF CHRONIC AMIODARONE ON REPERFUSION ARRHYTHMIAS IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3623-3623
Authors:
COSNIERPUCHEU S
GUIRAUDOU P
RIZZOLI G
CAZAUBON C
RICHAUD JP
GAUTIER P
NISATO D
Citation: S. Cosnierpucheu et al., EFFECTS OF SERUM-ALBUMIN ON AMIODARONE AND DRONEDARONE TISSUE DISTRIBUTION AND CARDIAC-FUNCTION IN THE PERFUSED RAT-HEART, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3629-3629
Authors:
LACOUR C
CANALS F
GALINDO G
SEGONDY D
CAZAUBON C
NISATO D
Citation: C. Lacour et al., KINETICS OF AQUARETIC AND HORMONAL EFFECTS OF AVP V-2 RECEPTOR BLOCKADE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5223-5223
Authors:
JOVER B
CASELLAS D
MIMRAN A
NISATO D
CAZAUBON C
Citation: B. Jover et al., RENAL EFFECTS OF COMBINED TREATMENT BY IRBESARTAN AND ENALAPRIL IN L-NAME HYPERTENSION IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3825-3825
Authors:
POLIDORI C
CICCOCIOPPO R
NISATO D
CAZAUBON C
MASSI M
Citation: C. Polidori et al., EVALUATION OF THE ABILITY OF IRBESARTAN TO CROSS THE BLOOD-BRAIN-BARRIER FOLLOWING ACUTE INTRAGASTRIC TREATMENT, European journal of pharmacology, 352(1), 1998, pp. 15-21
Authors:
DELBRUYERE M
CADENE A
SHIRE D
LEGOUX P
CAZAUBON C
NISATO D
Citation: M. Delbruyere et al., EFFECTS OF CHRONIC BLOCKADE OF AT(1) RECEPTORS ON THE REGULATION OF ALL RECEPTOR DENSITIES AND MESSENGER-RNA EXPRESSION OF THE RENIN-ANGIOTENSIN SYSTEM COMPONENTS, Circulation, 98(17), 1998, pp. 3798-3798
Authors:
CAZAUBON C
SEGONDY D
RICHAUD JP
GRIMA M
GARBAY JM
NISATO D
Citation: C. Cazaubon et al., EFFECTS OF CHRONIC BLOCKADE OF AT(1) RECEPTORS ON THE REGULATION OF PLASMA COMPONENTS OF THE RENIN-ANGIOTENSIN SYSTEM, Circulation, 98(17), 1998, pp. 4157-4157
Authors:
RICHERGIUDICELLI C
FORNES P
CAZAUBON C
NISATO D
GIUDICELLI JF
Citation: C. Richergiudicelli et al., EFFECTS OF ANGIOTENSIN-II ATI RECEPTOR BLOCKADE ON SURVIVAL, SYSTEMICAND CORONARY HEMODYNAMICS AND CARDIAC REMODELING IN POSTISCHEMIC HEART-FAILURE IN RATS, Circulation, 96(8), 1997, pp. 3605-3605
Authors:
BARTHELMEBS M
LOICHOT C
NISATO D
CAZAUBON C
GRIMA M
IMBS JL
Citation: M. Barthelmebs et al., BLOOD-PRESSURE AND RENAL EFFECTS OF SR-49059, A SELECTIVE VASOPRESSINV-1A RECEPTOR ANTAGONIST, IN HYPERTENSION INDUCED BY CHRONIC INHIBITION OF NITRIC, British Journal of Pharmacology, 122, 1997, pp. 203-203
Authors:
VACHER E
RICHER C
CAZAUBON C
FORNES P
NISATO D
GIUDICELLI JF
Citation: E. Vacher et al., ARE VASOPRESSIN PERIPHERAL V-1 RECEPTORS INVOLVED IN THE DEVELOPMENT OF MALIGNANT HYPERTENSION AND STROKE IN SHR-SPS, Fundamental and clinical pharmacology, 9(5), 1995, pp. 469-478
Authors:
CHRISTOPHE B
LIBON R
CAZAUBON C
NISATO D
MANNING A
CHATELAIN P
Citation: B. Christophe et al., EFFECTS OF IRBESARTAN (SR 47436 BMS-186295) ON ANGIOTENSIN-II-INDUCEDPRESSOR-RESPONSES IN THE PITHED RAT - POTENTIAL MECHANISMS OF ACTION/, European journal of pharmacology, 281(2), 1995, pp. 161-171
Authors:
FERRARI B
TAILLADES J
PERREAUT P
BERNHART C
GOUGAT J
GUIRAUDOU P
CAZAUBON C
ROCCON A
NISATO D
LEFUR G
BRELIERE JC
Citation: B. Ferrari et al., DEVELOPMENT OF TETRAZOLE BIOISOSTERES IN ANGIOTENSIN-II ANTAGONISTS, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 45-50
Authors:
BERNHART CA
HAUDRICOURT FB
ASSENS JL
GOUGAT J
LACOUR C
ROCCON A
CAZAUBON C
BRELIERE JC
LEFUR G
NISATO D
Citation: Ca. Bernhart et al., CYCLOPENTANESPIRO-3H-DIHYDRO-PYRIMIDINONES AS ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 157-162
Authors:
PERREAUT P
CLEMENT J
MUNEAUX C
MUNEAUX Y
CAZAUBON C
GOUGAT J
GUIRAUDOU P
LACOUR C
NISATO D
LEFUR G
BRELIERE JC
Citation: P. Perreaut et al., DIHYDRO-IMIDAZOLONE DERIVATIVES AS ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CHIRAL EFFECT ON THE ACTIVITY, Bioorganic & medicinal chemistry letters, 4(1), 1994, pp. 163-168
Authors:
LACOUR C
CANALS F
GALINDO G
CAZAUBON C
SEGONDY D
NISATO D
Citation: C. Lacour et al., EFFICACY OF SR-47436 (BMS-186295), A NONPEPTIDE ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST IN HYPERTENSIVE RAT MODELS, European journal of pharmacology, 264(3), 1994, pp. 307-316
Authors:
HERBERT JM
DELISEE C
DOL F
SCHAEFFER P
CAZAUBON C
NISATO D
CHATELAIN P
Citation: Jm. Herbert et al., EFFECT OF SR-47436, A NOVEL ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONIST,ON HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO, European journal of pharmacology, 251(2-3), 1994, pp. 143-150
Authors:
ROCCON A
MARCHIONNI D
DONAT F
SEGONDY D
CAZAUBON C
NISATO D
Citation: A. Roccon et al., A PHARMACODYNAMIC STUDY OF SR-47436, A SELECTIVE AT(1) RECEPTOR ANTAGONIST, ON BLOOD-PRESSURE IN CONSCIOUS CYNOMOLGUS MONKEYS, British Journal of Pharmacology, 111(1), 1994, pp. 145-150
Authors:
DELISEE C
SCHAEFFER P
CAZAUBON C
CHATELAIN P
Citation: C. Delisee et al., CHARACTERIZATION OF CARDIAC ANGIOTENSIN AT1 RECEPTORS BY [H-3] SR-47436, European journal of pharmacology. Molecular pharmacology section, 247(2), 1993, pp. 139-144
Authors:
HERBERT JM
DOL F
CAZAUBON C
DELISEE C
SCHAEFFER P
CHATELAIN P
NISATO D
Citation: Jm. Herbert et al., EFFECT OF SR-47436, A NOVEL ANGIOTENSIN-II ANTAGONIST ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO, Thrombosis and haemostasis, 69(6), 1993, pp. 802-802
Authors:
LACOUR C
ROCCON A
CAZAUBON C
SEGONDY D
NISATO D
Citation: C. Lacour et al., PHARMACOLOGICAL STUDY OF SR 47436, A NONPEPTIDE ANGIOTENSIN-II AT1-RECEPTOR ANTAGONIST, IN CONSCIOUS MONKEYS, Journal of hypertension, 11(11), 1993, pp. 1187-1194
Authors:
CAZAUBON C
GOUGAT J
BOUSQUET F
GUIRAUDOU P
GAYRAUD R
LACOUR C
ROCCON A
GALINDO G
BARTHELEMY G
GAUTRET B
BERNHART C
PERREAUT P
BRELIERE JC
LEFUR G
NISATO D
Citation: C. Cazaubon et al., PHARMACOLOGICAL CHARACTERIZATION OF SR-47436, A NEW NONPEPTIDE AT(1) SUBTYPE ANGIOTENSIN-II RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 826-834